A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers.

Award-winning patient advocate Trishna Bharadia speaks to Marco Ricci about the challenges facing people with multiple sclerosis (MS) and what needs to be done to improve management of this ...

The actress boosts awareness of MS as the West Hollywood-based neurologist works to limit its effect on patients ...

Hauser frets that amid federal cutbacks, young scientists may turn away from medical research, knee-capping health care ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced enrollment of ...

Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

In a recent case report published in Frontiers in Immunology, scientists in Canada described how an experimental treatment using a naturally derived substance called ibogaine appeared to improve ...

The following is a summary of “Effect of patient-centered empowerment program through telenursing on self-management in ...

A Blood Test Shows MS Worsening 1 to 2 Years Before It Happens Nov. 6, 2023 — Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening ...